Brunnekreef, Jaap J <br/><br/>
Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?  [electronic resource] 

 -  International orthopaedics  Apr 2013 
 - 583-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-5195 
<br/><br/><label>Standard No.: </label>10.1007/s00264-013-1781-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Arthroplasty, Replacement, Hip--adverse effects<br/>Cyclooxygenase 2 Inhibitors--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Etoricoxib<br/>Female<br/>Hip Joint--diagnostic imaging<br/>Hip Prosthesis<br/>Humans<br/>Male<br/>Middle Aged<br/>Ossification, Heterotopic--etiology<br/>Osteoarthritis, Hip--surgery<br/>Prospective Studies<br/>Pyridines--administration & dosage<br/>Radiography<br/>Severity of Illness Index<br/>Sulfones--administration & dosage<br/>Treatment Outcome